Press Release | Fri Jun 25, 2010 4:00pm IST

Human Genome Sciences Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA (Belimumab) at International Congress on SLE

* Reuters is not responsible for the content in this press release.